VEGF-targeted cancer therapeutics—paradoxical effects in endocrine organs
VEGF-targeted cancer therapeutics—paradoxical effects in endocrine organs
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Antiangiogenic drugs that target vascular endothelial growth factor A (VEGF-A; VEGF) signalling are widely used, either alone or in combination with chemotherapy, to treat various types of cancer
Vasculatures in endocrine organs are dependent on the VEGF–VEGF receptor signal transduction pathway for their survival, architecture and...
Alternative Titles
Full title
VEGF-targeted cancer therapeutics—paradoxical effects in endocrine organs
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_520110
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_520110
Other Identifiers
ISSN
1759-5029
E-ISSN
1759-5037
DOI
10.1038/nrendo.2014.114
